Counterpoint Quantitative Equity ETF (CPAI) review: it beat markets, has elevated risks. Read here for a detailed investment analysis.

The WisdomTree International Equity ETF (DWM) made its debut on 06/16/2006, and is a smart beta exchange traded fund that ...

XRP ETFs saw mixed performance on January 28, with XRPC, XRPZ, and GXRP recording inflows, while TOXR and XRP remained stable ...

I am initiating coverage of the Hartford Large Cap Growth ETF with a Hold rating due to existing risks and disadvantages. Actively managed, growth-focused HFGO offers stronger revenue, EBITDA, and EPS ...

Explore how IWM’s diversified small-cap mix and higher yield contrast with MGK’s focused tech giants and lower fees.

Led by Cathie Wood, the ARK Innovation ETF (ARKK) is an actively managed exchange-traded fund (ETF) that focuses on finding and investing in Wall Street’s most disruptive companies. Unlike passive ...

Designed to provide broad exposure to the Industrials - Water segment of the equity market, the Invesco Water Resources ETF (PHO) is a passively managed exchange traded fund launched on December 6, ...

Each month, we check in on the performance of the largest US stock, bond, and active exchange-traded funds. The Morningstar US Market Index rose 0.24% during November and is up 13.92% over the past ...

Vanguard Small-Cap ETF VB offers a well-diversified, low-turnover portfolio that is representative of the US small-cap market. These features, coupled with a minuscule fee, make it one of the best ...

Recent discussions on X about the VanEck Semiconductor ETF (SMH) have centered around its impressive performance and potential for future growth, particularly as the semiconductor industry continues ...

XRP fell 13% in 2025 despite beating the SEC and attracting over $1B in ETF inflows within weeks of launch. XRP ETF approval in November brought $1 billion in institutional inflows within four weeks ...

Eli Lilly And Co (NYSE: LLY) has officially become the giant quietly moving the strings behind a large slice of the pharma ETF universe. With blockbuster revenue growth, repeated earnings beats and a ...